Aboujaoudé G - Search Results

1

Multimodal method for landslide risk analysis.

Pollock W, Grant A, Wartman J, Abou-Jaoude G. Pollock W, et al. MethodsX. 2019 Apr 16;6:827-836. doi: 10.1016/j.mex.2019.04.012. eCollection 2019. MethodsX. 2019. PMID: 31049299 Free PMC article.

2

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.

Verrier ER, Colpitts CC, Bach C, Heydmann L, Weiss A, Renaud M, Durand SC, Habersetzer F, Durantel D, Abou-Jaoudé G, López Ledesma MM, Felmlee DJ, Soumillon M, Croonenborghs T, Pochet N, Nassal M, Schuster C, Brino L, Sureau C, Zeisel MB, Baumert TF. Verrier ER, et al. Hepatology. 2016 Jan;63(1):35-48. doi: 10.1002/hep.28013. Epub 2015 Oct 6. Hepatology. 2016. PMID: 26224662

3

Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies.

Julithe R, Abou-Jaoudé G, Sureau C. Julithe R, et al. J Virol. 2014 Aug;88(16):9049-59. doi: 10.1128/JVI.01161-14. Epub 2014 Jun 4. J Virol. 2014. PMID: 24899172 Free PMC article.

4

I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y.

LeGoff J, Rousset D, Abou-Jaoudé G, Scemla A, Ribaud P, Mercier-Delarue S, Caro V, Enouf V, Simon F, Molina JM, van der Werf S. LeGoff J, et al. PLoS One. 2012;7(8):e37095. doi: 10.1371/journal.pone.0037095. Epub 2012 Aug 24. PLoS One. 2012. PMID: 22936969 Free PMC article.

5

The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding.

Dussupt V, Javid MP, Abou-Jaoudé G, Jadwin JA, de La Cruz J, Nagashima K, Bouamr F. Dussupt V, et al. PLoS Pathog. 2009 Mar;5(3):e1000339. doi: 10.1371/journal.ppat.1000339. Epub 2009 Mar 13. PLoS Pathog. 2009. PMID: 19282983 Free PMC article.

6

Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.

Abou-Jaoudé G, Sureau C. Abou-Jaoudé G, et al. J Virol. 2007 Dec;81(23):13057-66. doi: 10.1128/JVI.01495-07. Epub 2007 Sep 26. J Virol. 2007. PMID: 17898062 Free PMC article.

7

Myristoylation signal transfer from the large to the middle or the small HBV envelope protein leads to a loss of HDV particles infectivity.

Abou-Jaoudé G, Molina S, Maurel P, Sureau C. Abou-Jaoudé G, et al. Virology. 2007 Aug 15;365(1):204-9. doi: 10.1016/j.virol.2007.03.030. Epub 2007 Apr 25. Virology. 2007. PMID: 17462692 Free article.

8

Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris. BET (Benefit Evaluation of Direct Coronary Stenting) Study Group.

Carrié D, Khalifé K, Citron B, Izaaz K, Hamon M, Juiliard JM, Leclercq F, Fourcade J, Lipiecki J, Sabatier R, Boulet V, Rinaldi JP, Mourali S, Fatouch M, El Mokhtar E, Aboujaoudé G, Elbaz M, Grolleau R, Steg PG, Puel J; Benefit Evaluation of Direct Coronary Stenting Study Group. Carrié D, et al. Among authors: aboujaoude g. Am J Cardiol. 2001 Mar 15;87(6):693-8. doi: 10.1016/s0002-9149(00)01485-5. Am J Cardiol. 2001. PMID: 11249885 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters